Pliant Therapeutics (PLRX) Total Liabilities (2019 - 2025)
Pliant Therapeutics (PLRX) has disclosed Total Liabilities for 7 consecutive years, with -$181.2 million as the latest value for Q4 2025.
- On a quarterly basis, Total Liabilities fell 295.12% to -$181.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$181.2 million, a 295.12% decrease, with the full-year FY2025 number at -$181.2 million, down 295.12% from a year prior.
- Total Liabilities was -$181.2 million for Q4 2025 at Pliant Therapeutics, down from $76.3 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $99.8 million in Q3 2024 to a low of -$181.2 million in Q4 2025.
- A 5-year average of $39.0 million and a median of $38.0 million in 2023 define the central range for Total Liabilities.
- Peak YoY movement for Total Liabilities: skyrocketed 213.83% in 2022, then tumbled 295.12% in 2025.
- Pliant Therapeutics' Total Liabilities stood at $22.2 million in 2021, then soared by 68.22% to $37.3 million in 2022, then increased by 3.51% to $38.6 million in 2023, then soared by 140.73% to $92.9 million in 2024, then crashed by 295.12% to -$181.2 million in 2025.
- Per Business Quant, the three most recent readings for PLRX's Total Liabilities are -$181.2 million (Q4 2025), $76.3 million (Q3 2025), and $79.7 million (Q2 2025).